CERE
Federated Hermes’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,214,972
| Closed | -$38.6M | – | 2230 |
|
|
2023
Q2 | $38.6M | Sell |
1,214,972
-710,000
| -37% | -$22.6M | 0.1% | 252 |
|
|
2023
Q1 | $47M | Sell |
1,924,972
-942,479
| -33% | -$23M | 0.12% | 218 |
|
|
2022
Q4 | $90.4M | Sell |
2,867,451
-445,882
| -13% | -$14.1M | 0.25% | 82 |
|
|
2022
Q3 | $93.6M | Buy |
3,313,333
+200,000
| +6% | +$5.65M | 0.27% | 79 |
|
|
2022
Q2 | $82.3M | Hold |
3,113,333
| – | – | 0.22% | 108 |
|
|
2022
Q1 | $109M | Hold |
3,113,333
| – | – | 0.25% | 104 |
|
|
2021
Q4 | $101M | Hold |
3,113,333
| – | – | 0.19% | 150 |
|
|
2021
Q3 | $91.8M | Buy |
3,113,333
+1,163,333
| +60% | +$34.3M | 0.17% | 162 |
|
|
2021
Q2 | $50M | Hold |
1,950,000
| – | – | 0.09% | 282 |
|
|
2021
Q1 | $26.8M | Buy |
1,950,000
+998,300
| +105% | +$13.7M | 0.05% | 423 |
|
|
2020
Q4 | $15.8M | Buy |
+951,700
| New | +$15.8M | 0.03% | 529 |
|